Volume 29, Issue 9 | International Journal of Clinical Oncology

Search all International Journal of Clinical Oncology articles

Volume 29, Issue 9

September 2024

Including Invited Reviews on Treatment strategy for advanced gastric cancer

20 articles in this issue

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval selpercatinib for solid tumor with RET fusion, gumarontinib for non-small cell lung cancer with MET gene exon 14 skipping mutation, momelotinib for myelofibrosis, bexarotene for adult T-cell leukemia/lymphoma, valemetostat for peripheral T-cell lymphoma, and pirtobrutinib for mantle cell lymphoma in Japan
Noriomi Matsumura
Masaki Mandai
PMDA Regulatory Update 15 July 2024 Pages: 1207 - 1208
Part of 1 collection:

PMDA regulatory updates
Statistics of bone sarcoma in Japan: report from the population-based cancer registry in Japan
Koichi Ogura
Chigusa Morizane
Akira Kawai
Cancer Statistics 11 June 2024 Pages: 1209 - 1219
Advances in the treatment of human epidermal growth factor receptor 2-positive gastric cancer
Toshihiro Kudo
Invited Review Article 31 July 2024 Pages: 1220 - 1227
New therapeutic target molecules for gastric and gastroesophageal junction cancer
Hisato Kawakami
Invited Review Article 17 April 2024 Pages: 1228 - 1236
Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancer
Naohiro Nishida
Daisuke Sakai
Taroh Satoh
Invited Review Article Open access 11 May 2024 Pages: 1237 - 1243
The miR-199a-5p/HIF1α dual-regulatory axis participates in hypoxia-induced aggressive phenotypes of oral squamous cell carcinoma (OSCC) cells
Xing Chen
Jianjun Yu
Xu Cai
Original Article 09 June 2024 Pages: 1244 - 1254
CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism
Koichi Hayano
Gaku Ohira
Hisahiro Matsubara
Original Article Open access 22 May 2024 Pages: 1255 - 1262
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis
Yuan Li
E-er-man-bie-ke Jin-si-han
Zhenhai Lu
Original Article 05 June 2024 Pages: 1263 - 1273
Marital status after colorectal surgery in familial adenomatous polyposis: a nationwide multicenter study in Japan
Kenji Fujiyoshi
Tomoya Sudo
Yoichi Ajioka
Original Article 31 May 2024 Pages: 1274 - 1283
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201)
Yutaka Ogata
Sotaro Sadahiro
Satoshi Morita
Original Article Open access 04 June 2024 Pages: 1284 - 1292
Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer
Shingo Maeda
Akira Ouchi
Yasuhiro Shimizu
Original Article 21 June 2024 Pages: 1293 - 1301
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
Kenji Tanabe
Shuichiro Kobayashi
Yasuhisa Fujii
Original Article 04 June 2024 Pages: 1302 - 1310
Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort
Makito Miyake
Nobutaka Nishimura
On behalf of the Nara Urological Research and Treatment Group
Original Article 18 June 2024 Pages: 1311 - 1325
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy
Takeru Fujimoto
Takayuki Goto
Takashi Kobayashi
Original Article 17 June 2024 Pages: 1326 - 1333
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models
Reika Kawabata-Iwakawa
Norihiro Iwasa
Masahiko Nishiyama
Original Article 20 May 2024 Pages: 1334 - 1346
Comorbid thrombosis as an adverse prognostic factor in patients with ovarian clear cell carcinoma regardless of staging
Kohei Yamaguchi
Tetsushi Tsuruga
Yutaka Osuga
Original Article 22 July 2024 Pages: 1347 - 1353
AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells
Yuki Iida
Mitsuhiko Osaki
Futoshi Okada
Original Article 29 May 2024 Pages: 1354 - 1363
Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer
Yuki Kochi
Satoshi Hosoya
Aikou Okamoto
Original Article 12 June 2024 Pages: 1364 - 1379
Prognostic significance of adjuvant chemotherapy in stage I–II endometrial carcinoma patients who underwent lymphadenectomy
Jiro Suzuki
Hiroshi Tanabe
Aikou Okamoto
Original Article 19 June 2024 Pages: 1380 - 1390
The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone
Yu Toda
Koichi Ogura
Akira Kawai
Original Article 12 July 2024 Pages: 1391 - 1397